White Paper
Importation Of Drugs Is Back Again On The Pharma Public Policy Table – A Short Commentary
This commentary white paper provides reasons why importation is still a bad idea today, but more importantly, why the reintroduction of this policy is a reflection of the broader e ...
Report
Future Of Pharma: Evolving Commercial Models – Part 2
Learn what several senior pharma commercial operations leaders think of the potential implications of industry challenges on business operations, sales and marketing objectives and ...
Report
Future Of Pharma: Evolving Commercial Models – Part 1
The pharmaceutical industry is in a state of flux with the increasing influence of payers, pressure from the government with restricted healthcare budgets, and the rise of multi-ch ...
White Paper
Challenges And Opportunities To Commercialize Orphan Drugs For Rare Diseases In The US
This white paper explores the unique challenges of ODs for RDs and the different approaches needed to address specific questions for their successful commercialization that vary fr ...
White Paper
Regional Sales And Marketing Optimization Modeling: A Call For Technical Changes
The concept of “all marketing is local” in the pharma environment is more valid today than ever before. We see tremendous variations in salient factors that would affect commer ...
White Paper
Is it Time to Adjust the Pharma PDE Sales Force Optimization Model?
The question this white paper addresses is straightforward – Is it time to adjust the long-standing pharma PDE (primary detail equivalent) sales force optimization model? The PDE ...
White Paper
Pharma Sales And Marketing Restrictions – Has the Pendulum Swung Too Far?
The question this commentary asks is simply this – has the pendulum swung too far in the direction of excessive restrictions on sales and marketing practices of biopharmaceut ...
White Paper
Measuring Sales Rep-Physician Relationship Disruption In Sales Force Optimization & Territory Alignment
There is a growing importance of maintaining sales rep-physician relationships and accounting for their disruption in sales force optimization and territory alignment analyses. Thi ...
White Paper
Enabling Smarter Commercial Model Experimentation
The pharmaceutical industry is changing and manufacturers need to modify approaches and structures to survive in a competitive environment. ...
White Paper
Account Based Models In An Institutional Setting
The stakeholders and factors that drive the ultimate prescribing of a medication have shifted considerably since the turn of the century. ...
